Clinical Trials Innovation Regulation and Costs - Working Session - World Health Summit 2009 WS-435

     Related Videos
Clinical Trials part 3
Clinical Trials part 4
Clinical Trials part 1
Protocol in Clinical Trials 10 of 13
Who Participates in Clinical Trials? 2 of 8

     More from this user

     Related Groups


     More on Sciencestage.com


 
  • Video url:                           Embed code: 

  • WHS2009-Oct-17  status
    (0) (0 Votes)
    Views: (1231)   Date: (06-05-10)   Time: (00:00:39)
  • Description:

    Working Session

    Clinical Trials: Innovation, Regulation and Costs




    Co-Host: German Research Foundation

    Chairs: Jürgen Schölmerich | Vice President | German Research Foundation (Deutsche Forschungsgemeinschaft)

    Liselotte Højgaard | Professor & Director & Chair of the European Medical Research Council | Copenhagen

    University Hospital




    Outline: R&D productivity in the pharmaceutical industry as measured by bringing innovative therapeutics to market is at a low level. Clinical trials, the bedrock of pharmaceuticals R&D, have become the major time-consuming driver of costs and complexity.

    The clinical paradigm is suffering from its regulatory burden, especially from complexity of varying national standards. It is not

    prepared well to deal effectively with non-pharmacological therapeutics and advances such as personalized medicine and

    regenerative medicine. Risk aversiveness is limiting the potential for new designs and statistical methods. The full potential of

    patient stratification and use of biomarkers remains to be captured as well.

    Furthermore, incentivation of industry on diseases with large patient populations and investigator-/academia-driven clinical

    research under severe strain leaves many innovation opportunities untapped and, hence, public health needs unaddressed.

    Especially investigator-driven clinical research is suffering from limited funding, lack of capabilities and huge complexity to deal

    with (e.g., data sharing, intellectual property issues, regulatory burden).

    In summary, we see untapped opportunities for innovation and a worsening trend of more complex regulations and more

    complex protocols facing implementation challenges with too large patient populations. Academia, funding agencies, regulatory

    agencies, and industry can resolve this multi-factorial issue only jointly.

    This interactive working session will provide an insider’s view on the problem from the perspectives of investigators, funding

    agencies, industry, and regulatory agencies. The aspiration is to conclude with a strong call for action on how to improve clinical

    medical research in Europe and globally: how to limit the regulatory burden for national and multinational trials, how to optimize

    targets and patient selection for clinical trials and how to assure trials of optimal statistical power, how to increase funding to

    investigator-driven clinical trials, and how to capture benefits of scientific advances through encouraging new designs. This task

    calls for collaboration of all relevant stakeholders.




    11.00 Problem Statement

    Jürgen Schölmerich | Vice President | German Research Foundation (Deutsche Forschungsgemeinschaft)




    11.05 The Investigator’s Perspective

    Brian Feagan | Director of Robarts Clinical Trials | Robarts Research Institute

    Multiple issues should be considered in selecting patients for clinical trials. True experiments in humans must be conducted under optimal ethical and scientific conditions with patient safety being the ultimate consideration. Frequently tension exists between

    selecting patients that are most likely to respond to an intervention (efficacy) and assessment of the intervention’s benefit in the

    “real world” (effectiveness). Designers of clinical trials must make wise decisions regarding patient selection if meaningful results

    are to be obtained. Examples from recent clinical trials will be used to explore these issues.


    &nb

     Related Documents

     Related Wikipedia Results

     Related Pubmed Results

     Related Nature.com Results

     Related on Youtube Results
  • Project "WA(i)STED"- preliminary clinical trials
    Project "WA(i)STED"- preliminary clinical trials Project Wa(i)sted - preliminary clinical trials by Scott MacLeod and Jakub Kalousek. From: Eva Porovat Views: 1 0 ratings Time: 01:11 More in Education
  • Experts provide much-needed policy analysis for clinical integration of next generation sequencing
    Experts provide much-needed policy analysis for clinical integration of next generation sequencing Experts provide much-needed policy analysis for clinical integration of next generation sequencing. From: YUth21 Views: 0 0 ratings Time: 02:42 More in People & Blogs
  • Boardman Clinical Group Video
    Boardman Clinical Group Video Boardman Clinical Group Community Video. From: Sara Kimbrell Views: 0 0 ratings Time: 05:59 More in People & Blogs
  • Live Clinical Tutorial - Zirconia Anterior Kinder Krowns
    Live Clinical Tutorial - Zirconia Anterior Kinder Krowns From: Brandon Richards Views: 0 0 ratings Time: 06:31 More in Education
  • Colchões Akmos Clinical Franquia ABC
    Colchões Akmos Clinical Franquia ABC Colchão Terapêutico Akmos. Auxilia na Prevenção Contra Doenças tais como: Infarto, Hipertensão, Osteoporose, Fibromialgia, Derrame e também no Tratamento de Problemas de Coluna. Possui... From: Franquia Akmos ABC - SP Views: 0 0 ratings Time: 00:33 More in People & Blogs
  • Diabetes Miracle New Angle Backed By Real Clinical Studies Review
    Diabetes Miracle New Angle Backed By Real Clinical Studies Review Diabetes Miracle - New Angle Backed By Real Clinical Studies : Brand New Diabetes Reversal Program. Just Launched. Get now http://bit.ly/1v9relV Tags Get Diabetes Miracle, Diabetes Miracle... From: Health and Fitness Views: 1 0 ratings Time: 09:19 More in People & Blogs
  • 7/30/14 ACC Best Practices & Clinical Transformation Meeting: Grant Project
    7/30/14 ACC Best Practices & Clinical Transformation Meeting: Grant Project Dr. Jay Rabinowitz and Dr. Lindsey Einhorn review Parker Pediatrics & Adolescents' Grant Project. From: COAVC3 Views: 1 0 ratings Time: 09:26 More in Education
  • 7/30/14 ACC Best Practices & Clinical Transformation Meeting: TeleMental Health
    7/30/14 ACC Best Practices & Clinical Transformation Meeting: TeleMental Health Dr. Jay Shore explains Access Care Technologies TeleMental Health initiatives. From: COAVC3 Views: 0 0 ratings Time: 04:36 More in Education
  • 7/30/14 ACC Best Practices & Clinical Transformation Meeting: Innovation Programs
    7/30/14 ACC Best Practices & Clinical Transformation Meeting: Innovation Programs Laura Hill and Brie Reimann explain Colorado Access Behavioral Health Innovation Programs. From: COAVC3 Views: 1 0 ratings Time: 03:35 More in Education
  • Paul Cirangle, MD; Sleeve Gastrectomy Clinical Experience; Chapter 8: Tissue Reinforcement
    Paul Cirangle, MD; Sleeve Gastrectomy Clinical Experience; Chapter 8: Tissue Reinforcement Paul Cirangle, MD; Sleeve Gastrectomy Clinical Experience; Chapter 8: Tissue Reinforcement Clinical Experiences with Covidien's Tri-Staple™ and LigaSure™ technologies; Dr. Paul Cirangle... From: covidienplc Views: 0 0 ratings Time: 02:03 More in Entertainment
  • Dr. S.K.Joshi clinical view
    Dr. S.K.Joshi clinical view From: BUDHANARAYAN Views: 0 0 ratings Time: 02:30 More in People & Blogs
  • Webinar #101: Best Practices & Common Pitfalls to Avoid in Global Clinical Trials
    Webinar #101: Best Practices & Common Pitfalls to Avoid in Global Clinical Trials 45% of clinical trials are conducted exclusively in non-U.S. countries, and only 6% are registered in both the U.S. and rest of the world. The globalization of clinical trials demands deeper... From: ImperialCRS Views: 0 0 ratings Time: 51:22 More in Science & Technology
  • Highlights from ATS 2014: Top Line Clinical Trial Results
    Highlights from ATS 2014: Top Line Clinical Trial Results ASCEND, INPULSIS, and PANTHER and are random controlled clinical trials of emerging therapies for IPF. Three experts present the study design, inclusion criteria, and results of these trials.... From: The France Foundation Views: 6 0 ratings Time: 15:04 More in Education
  • Highlights from ATS 2014: Discussions on Clinical Trial Data
    Highlights from ATS 2014: Discussions on Clinical Trial Data ASCEND, INPULSIS, and PANTHER are further covered in a roundtable format. Our experts explore the clinical endpoints, inclusion criteria, and clinical implications of these recent trials. The... From: The France Foundation Views: 27 0 ratings Time: 36:26 More in Education
  • Highlights from ATS 2014: Update on Predicting Clinical Progression
    Highlights from ATS 2014: Update on Predicting Clinical Progression Our expert panel discusses new developments in biomarkers of IPF and disease progression. Studies of familial IPF reveal biochemical changes in the absence of clinical disease. Luca Richeldi,... From: The France Foundation Views: 17 0 ratings Time: 16:23 More in Education
  • Dr Charles Gostling, GP Lewisham, Clinical Director, Diabetes - Health Innovation Network
    Dr Charles Gostling, GP Lewisham, Clinical Director, Diabetes - Health Innovation Network Dr Charles Gostling introducing the Health Innovation Network's toolkit for the optimal delivery of Structured Education for Type 2 Diabetes. From: Health Innovation Network Views: 0 0 ratings Time: 02:44 More in People & Blogs
  • Dr Charles Gostling, GP Lewisham, Clinical Director, Diabetes - Health Innovation Network
    Dr Charles Gostling, GP Lewisham, Clinical Director, Diabetes - Health Innovation Network Dr Charles Gostling introducing the Health Innovation Network's toolkit for the optimal delivery of Structured Education for Type 2 Diabetes. From: Health Innovation Network Views: 1 0 ratings Time: 02:44 More in People & Blogs
  • Clinical sound and Lighting appreciates teamwork
    Clinical sound and Lighting appreciates teamwork At CSL it is imperative that we work as a team to achieve even the simplest of tasks.. From: Clinical Enterprises Views: 0 0 ratings Time: 00:50 More in People & Blogs
  • The Clinical Relevance of Awakening Part 2: Not-self
    The Clinical Relevance of Awakening Part 2: Not-self David Vago, PhD and Lisa Dale Miller, LMFT, LPCC, SEP recently recorded two rich and informative conversations focused on translating the Buddhist concept of “enlightenment” into modern... From: Lisa Dale Miller, LMFT, LPCC, SEP Views: 6 0 ratings Time: 22:35 More in Education
  • The Clinical Relevance of Awakening Part 2: The S-ART Model
    The Clinical Relevance of Awakening Part 2: The S-ART Model David Vago, PhD and Lisa Dale Miller, LMFT, LPCC, SEP recently recorded two rich and informative conversations focused on translating the Buddhist concept of “enlightenment” into modern... From: Lisa Dale Miller, LMFT, LPCC, SEP Views: 11 0 ratings Time: 09:55 More in Education
  • Clinical Documentation Improvement Means Better Quality Care
    Clinical Documentation Improvement Means Better Quality Care Regardless of the ICD-10 deadline, Jennifer Woodworth, Director of Clinical Documentation Integrity at Swedish Medical Center, emphasizes better documentation leads to better quality care. From: Nuance Healthcare Views: 26 0 ratings Time: 00:56 More in Science & Technology
  • Grants For Becoming A Certified Clinical Nutritionist
    Grants For Becoming A Certified Clinical Nutritionist From: Scholarships Views: 0 0 ratings Time: 01:28 More in Howto & Style
  • Welcome To Harrison College Medical Assistant Clinical Courses!
    Welcome To Harrison College Medical Assistant Clinical Courses! From: Eleanor Reynolds Views: 3 0 ratings Time: 09:01 More in People & Blogs
  • clinical pharmacy
    clinical pharmacy From: emma sanchez Views: 4 0 ratings Time: 08:26 More in People & Blogs
  • AppwoRx Clinical Photo Manager
    AppwoRx Clinical Photo Manager From: CHRISTOPHER Cabell Views: 0 0 ratings Time: 01:21 More in Comedy

  •      Related Answers Results



























       

      Powered free by PHPmotion